4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-22-006087
Chief Scientific Officer acquired 1,858 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Steven F. Chief Scientific Officer | 2022-08-11 | Option exercise | +1,858 | $3.72 | $6,912 | 121,957 | D |
| Derivatives | |||||||
| Bellon Steven F. Chief Scientific Officer | 2022-08-11 | Option exercise · Stock Options (Right to buy) | −1,858 | 3,716 | D | ||
Loading xslF345X03/primarydocument.xml…